Announcements Trials
Browse Landscape

Phase

Phase 2 35Phase 1/2 9Phase 1 9Phase NA 7Phase EARLY_PHASE1 6Phase 3 5Phase 2/3 1

Status

Recruiting 4Active not recruiting 1

Sponsor Class

INDUSTRY 4OTHER 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 5Other hematologic neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 62Breast Neoplasms 44Prostatic Neoplasms 35Lung Neoplasms 29Multiple Myeloma 24Neoplasms 22Colorectal Neoplasms 19Parkinson Disease 4, Autosomal Dominant Lewy Body 18Ovarian Neoplasms 17Neoplasm Metastasis 17Leukemia, Lymphocytic, Chronic, B-Cell 17Carcinoma, Renal Cell 15Pancreatic Neoplasms 13Small Cell Lung Carcinoma 12Endometrial Neoplasms 12Urinary Bladder Neoplasms 10Stomach Neoplasms 10Squamous Cell Carcinoma of Head and Neck 10Leukemia, Myeloid, Acute 10Myasthenia Gravis 9Lymphoma, Follicular 9Fallopian Tube Neoplasms 9Non-Muscle Invasive Bladder Neoplasms 8Colonic Neoplasms 8Recurrence 7Burkitt Lymphoma 7Lymphoma, Mantle-Cell 6Esophageal Neoplasms 6Carcinoma 6Biliary Tract Neoplasms 6

Interventions

obinutuzumab 3Rituximab 2Lenalidomide 2Bendamustine Hydrochloride 2zanubrutinib 1tocilizumab 1pirtobrutinib 1ibrutinib 1glofitamab 1acalabrutinib 1Vincristine 1Radiotherapy 1Prednisone 1Doxorubicin 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 3 × Lymphoma × 30 days × Clear all
NCT06084936 2026-06-03

GLOBRYTE

Hoffmann-La Roche

Phase 3 Recruiting
182 enrolled
Lymphoid

Lymphoma

NCT06191744 2026-06-02

EPCOREâ„¢FL-2

Genmab

Phase 3 Recruiting
1,095 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Neoplasms

NCT05929222 2026-06-01

FIL_GAZEBO

Fondazione Italiana Linfomi - ETS

Phase 3 Recruiting
190 enrolled
Lymphoid

Lymphoma, Lymphoma, Follicular, Neoplasm, Residual

NCT07509151 2026-06-01

SOUNDTRACK-C1

AstraZeneca

Phase 3 Recruiting
420 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Leukemia, B-Cell

NCT04662255 2026-05-15

BRUIN-MCL-321

Eli Lilly and Company

Phase 3 Active not recruiting
500 enrolled
Lymphoid

Hematologic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡